1. Simvastatin suppresses the DNA replication licensing factor MCM7 and inhibits the growth of tamoxifen-resistant breast cancer cells.
- Author
-
Liang Z, Li W, Liu J, Li J, He F, Jiang Y, Yang L, Li P, Wang B, Wang Y, Ren Y, Yang J, Luo Z, Vaziri C, and Liu P
- Subjects
- Animals, Antineoplastic Agents, Hormonal pharmacology, Apoptosis drug effects, Biomarkers, Tumor, Breast Neoplasms metabolism, Cell Cycle drug effects, Cell Line, Tumor, Cell Proliferation drug effects, DNA Damage, Disease Models, Animal, Drug Synergism, Female, Gene Expression, Gene Knockdown Techniques, Histones genetics, Histones metabolism, Humans, Mice, Minichromosome Maintenance Complex Component 7 genetics, Minichromosome Maintenance Complex Component 7 metabolism, Retinoblastoma Protein genetics, Retinoblastoma Protein metabolism, Xenograft Model Antitumor Assays, DNA Replication drug effects, Drug Resistance, Neoplasm drug effects, Hydroxymethylglutaryl-CoA Reductase Inhibitors pharmacology, Minichromosome Maintenance Complex Component 7 antagonists & inhibitors, Simvastatin pharmacology, Tamoxifen pharmacology
- Abstract
Acquired tamoxifen resistance (TamR) remains a major challenge in breast cancer endocrine therapy. The mechanism of acquiring tamoxifen resistance remains elusive, and no effective drugs are available. In this investigation, we determined that the expression of the DNA damage marker γH2AX is upregulated under minichromosome maintenance protein 7 (MCM7) knockdown in phospho Ser807/811-retinoblastoma protein (p-Rb) defect cells. In addition, the expression of p-Rb was lower in TamR cells than in parental cells, and the expression of γH2AX was significantly upregulated when MCM7 was knocked down in TamR cells. Simvastatin, an agent for hypercholesterolemia treatment, activated the MCM7/p-RB/γH2AX axis and induced DNA damage in TamR cells, especially when combined with tamoxifen. Finally, in vitro and in vivo experiments demonstrated that simvastatin combined with tamoxifen increased TamR cell apoptosis and inhibited xenograft growth. In conclusion, simvastatin may suppress TamR cell growth by inhibiting MCM7 and Rb and subsequently inducing DNA damage., Competing Interests: The authors declare no competing financial interests. more...
- Published
- 2017
- Full Text
- View/download PDF